Malaria is the leading cause of death for children under five. The
Malaria Consortium distributes preventive seasonal malaria chemoprevention (SMC) drugs during the high malaria season to hundreds of thousands of children in several countries who would not otherwise receive this life-saving treatment.
GiveWell estimates that the Malaria Consortium’s work is eight times as cost-effective as unconditional cash transfers. There is strong evidence that
SMC reduces malaria and likely provides additional benefits, such as later-life income.